Electronic versions

Documents

DOI

Adding adalimumab to methotrexate reduced the average risk over time of treatment failure in refractory uveitis associated with juvenile idiopathic arthritis by 75%.
Original languageEnglish
Pages (from-to)1-174
Number of pages174
JournalHealth Technology Assessment
Volume23
Issue number15
DOIs
Publication statusPublished - 10 Apr 2019
View graph of relations